17:00 Mon 22 Jun 2020
Mediclinic Intnl plc - Director/PDMR Shareholding
(Incorporated in
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
("Mediclinic", or the "Company", or the "Group")
NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
On
The following notification is made in accordance with Articles 19.1 and 19.3 of the Market Abuse Regulation.
1. |
Details of PDMR / person closely associated with them ("PCA")
|
|||||||||||||||||||||||
a) |
|
|
||||||||||||||||||||||
2. |
Reason for the notification
|
|||||||||||||||||||||||
a) |
Position / status |
PCA of
|
||||||||||||||||||||||
b) |
Initial notification / amendment |
Initial Notification
|
||||||||||||||||||||||
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
|
|||||||||||||||||||||||
a) |
|
|
||||||||||||||||||||||
b) |
LEI |
2138002S5BSBIZTD5I60
|
||||||||||||||||||||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
|
|||||||||||||||||||||||
a) |
Description of the financial instrument
Identification Code |
Ordinary Shares
GB00B8HX8Z88
|
||||||||||||||||||||||
b) |
Nature of the transaction |
Sale of shares
|
||||||||||||||||||||||
c) |
Price(s) and volume(s) |
|
||||||||||||||||||||||
d) |
Aggregated information
Aggregated volume
Price |
25 904
ZAR 58.51 per share
|
||||||||||||||||||||||
e) |
Date of the transaction |
|
||||||||||||||||||||||
f) |
Place of the transaction |
|
About
Mediclinic is an international private healthcare services group, established in
The Group's core purpose is to enhance the quality of life.
Its vision is to be the partner of choice that people trust for all their healthcare needs.
Mediclinic is focused on providing specialist-orientated, multi-disciplinary services across the continuum of care in such a way that the Group will be regarded as the most respected and trusted provider of healthcare services by patients, medical practitioners, funders and regulators of healthcare in each of its markets.
At
The Company's primary listing is on the
Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, a leading private healthcare group based in the
For further information, please contact:
Company Secretary,
+44 (0)20 7954 9548
Investor Relations,
+44 (0)20 3786 8181
Media queries
FTI Consulting
+44 (0)20 3727 1000
+27 (0)21 487 9000
Registered address: 6th Floor,
Website: www.mediclinic.com
Corporate broker (
JSE sponsor (
NSX sponsor (
This information is provided by RNS, the news service of the
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of...
FOR OUR FULL DISCLAIMER CLICK HERE